ArticleCancer immunology, immunotherapy : CII2025

In situ treatment with a TLR9 agonist virus-like particle to promote immune responses against oral epithelial dysplasia progression.

Yan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.